From Nov 5 to 7, 2024, Haimen Pharma Inc., (Haimen Pharma), has received an on-site inspection by the Saudi Food and Drug Authority (SFDA). The inspection covered the following systems: quality, production, facilities and equipment, laboratory materials and packaging labels etc system.
Recently, Haimen Pharma received a “Notice of GMP Compliance Inspection Results” issued by SFDA, confirming that it has passed the SFDA inspection. This result is not only a recognition of the operation excellence of production and quality management system of Haimen Pharma, but also establishment of a solid foundation for expanding the market of Middle East.
About SinoT：
SinoT is a specialty pharma with focus on the research & development, commercialization and sale of complex generics and 505(b2) products. We dedicated to developing high quality medicines that meet with international standards. We’ll do more than our best to benefit the patients in the future.
Shanghai Head Office
99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China
Manufacturing Site in Jiangsu
No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province
